All these findings, together with the evidence of higher maximum rates of thrombin production in COPD patients [21], allowed us to evaluate PAR-1 expression and activation in airway epithelial cells from the central and distal airways. This evidence concerns the gene F2R and chronic obstructive pulmonary disease.